Rituximab Iodination Procedure for Radioiodinated Rituximab (131I-Rituximab) Preparation

Rituximab is a chimeric monoclonal antibody which has specific for CD20 antigen expressed by pre-B and mature B-cells. Radiolabelled Rituximab, 131I-Rituximab, has been sucessfully used for treatment of B-Cell NHL. Due to its short shelf-life, 131I-Rituximab is commonly freshly prepared in hospitals...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Martalena Ramli, Basuki Hidayat, Sutari Sutari, Sri Setyowati, Veronica Yulianti Susilo
Médium: Artigo
Jazyk:Inglês
Vydáno: Universitas Padjajaran 2019-06-01
Edice:Majalah Kedokteran Bandung
Témata:
rituximab, i-131
radiolabelling procedure
validation
On-line přístup:http://journal.fk.unpad.ac.id/index.php/mkb/article/view/1595
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky